Many transgender and gender diverse adolescents and young adults will pursue hysterectomy for the purpose of gender affirmation. This procedure often includes bilateral salpingo-oophorectomy (BSO), which has potential implications for long-term health should individuals choose to stop, or lose access to, exogenous testosterone. Although most of these individuals intend to remain on testosterone indefinitely, not all do, and little information exists on such cases following bilateral oophorectomy to guide counseling and practice. This case series documents 3 individuals who had interruptions in their testosterone use after hysterectomy with BSO for reasons including external barriers, internal barriers, and concerns about side effects. Patients should be appropriately counseled on hysterectomy options as bilateral oophorectomy is not required in the absence of specific indications.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Pediatric and Adolescent Gynecology
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Gender-affirming surgeries in transgender and gender diverse adolescent and young adults: a pediatric and adolescent gynecology primer.J Pediatr Adolesc Gynecol. 2021; 34: 442-448
- Ovarian histopathology in transmasculine persons on testosterone: a multicenter case series.J Sex Med. 2020; 17: 1807-1818
- The Report of the 2015 US Transgender Survey.NationalCenter for Transgender Equality, Washington, D.C.2016
- Salpingo-oophorectomy at the time of benign hysterectomy: a systematic review.Obstet Gynecol. 2016; 128: 476-485
- Empowering transmasculine youth by enhancing reproductive health counseling in the primary care setting.J Adolesc Health. 2020; 66: 653-655https://doi.org/10.1016/j.jadohealth.2020.03.012
- Endocrine treatment of gender-dysphoric/gender-incongruent persons: an endocrine society clinical practice guideline.J Clin Endocrinol Metab. 2017; 102: 3869-3903
- Primary ovarian insufficiency in adolescents and young women.Obstet Gynecol. 2014; 124: 193-197https://doi.org/10.1097/01.AOG.0000451757.51964.98
- ACOG Committee Opinion No. 774: Opportunistic salpingectomy as a strategy for epithelial ovarian cancer prevention.Obstet Gynecol. 2019; 133: e279-e284https://doi.org/10.1097/AOG.0000000000003164
Published online: July 14, 2022
Accepted: July 11, 2022
Received in revised form: July 9, 2022
Received: May 10, 2022
Conflict of Interest Statement: The authors have no conflicts of interest to disclose.
© 2022 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc. All rights reserved.